Paying Cash Can Help Exit Medicare Drug Doughnut Hole
Counting your out-of-pocket costs for prescriptions under Medicare can get you out of the coverage gap faster.
Given the high cost of many prescription drugs, you sometimes are better off paying a lower cash price instead of using insurance. Why? Because, in some cases, the Medicare co-pay can be higher than the out-of-pocket expense for the same medicine, especially if you can use a discount coupon.
The strategy drew attention recently because of a new law that bans “gag clauses,” which had prevented pharmacists in some states from letting customers know about a lower price for their drugs if they paid cash or didn’t use insurance. The clauses had been regularly included in pharmacy contracts with insurers. The ban takes effect immediately for private insurance and is effective January 1, 2020, for Medicare Advantage and Part D prescription-drug plans. If you know to ask about a lower price, the pharmacist is permitted to tell you, even before the ban starts (see New Laws Lift 'Gag Clauses' on Pharmacists).
But what you may not realize is that if you have Medicare Part D or Medicare Advantage, and you pay the lower cash price at a pharmacy in your plan, the money you pay can count toward your out-of-pocket expenses. You will have to submit documentation to your Part D or Advantage plan, and you will be credited up to the amount of the co-payment or the co-insurance you would have paid under your insurance, says Julie Carter, senior federal policy associate at the Medicare Rights Center.
Sign up for Kiplinger’s Free E-Newsletters
Profit and prosper with the best of expert advice on investing, taxes, retirement, personal finance and more - straight to your e-mail.
Profit and prosper with the best of expert advice - straight to your e-mail.
People definitely are not aware of this policy for the most part,” Carter says. “Still, all of the news around gag clauses and the cash price could mean people need to know this information more than before.”
Why It Matters
Having your out-of-pocket costs count under Medicare is important because the expenses you incur count toward getting you out of the coverage gap known as the doughnut hole. For 2018, once you and your plan have spent $3,750 on covered drugs, you’re in the doughnut hole. In the gap, you pay 35% of the costs of brand-name drugs and 44% of the cost for generics. Once you exceed $5,000 in out-of-pocket spending, you’re out of the coverage gap, and you automatically get “catastrophic coverage.” You face only a small co-insurance or co-payment of about 5% for covered drugs for the rest of the year. The coverage gap changes in 2019 (see below). Making sure your cash outlays for a drug count toward your total out-of-pocket costs can help you exit the coverage gap more quickly.
Some Medicare beneficiaries hear about the policy only if their pharmacist happens to know and shares the information, says Leslie Fried, senior director for benefits access at the National Council on Aging.
Though slightly hard to find, the policy is included in the Medicare Prescription Drug Benefit Manual at cms.gov (here's a link to the policy; go to the chapter titled "Direct Member Reimbursement"). Call your Part D or Advantage plan to confirm it will count your expenses and to get information on the necessary documentation, Fried says.
You also should keep all your receipts. Then be sure to follow through and submit your documentation. “It will require you to jump through some hoops,” Fried says.
Doughnut Hole in 2019
Initial Coverage Period. You pay up to your annual deductible (the standard Part D deductible is $415). Then you pay 25% of prescription-drug costs up to $3,820.
Coverage Gap for Generics. For 2019, the doughnut hole closes for brand-name drugs -- you pay 25% of those costs until reaching catastrophic coverage. But the coverage gap remains for generics -- you pay 37% of those costs while in the coverage gap.
Exit the Gap. Once out-of-pocket costs total $5,100 in 2019, you exit the coverage gap. Catastrophic coverage kicks in, and you now pay the greater of 5% of drug costs or $3.40 for generics and $8.50 for brand-name drugs.
To continue reading this article
please register for free
This is different from signing in to your print subscription
Why am I seeing this? Find out more here
-
Stock Market Today: Nasdaq Soars Ahead of Tesla Earnings
The EV stock rose nearly 2% ahead of its highly anticipated Q1 earnings report, due after tonight's close.
By Karee Venema Published
-
GM Stock Accelerates After Earnings Beat
General Motors beat expectations for the first quarter and raised its outlook for the year. Here's what you need to know.
By Joey Solitro Published
-
403(b) Contribution Limits for 2024
retirement plans Teachers and nonprofit workers can contribute more to a 403(b) retirement plan in 2024 than they could in 2023.
By Jackie Stewart Published
-
SEP IRA Contribution Limits for 2024
SEP IRA A good option for small business owners, SEP IRAs allow individual annual contributions of as much as $69,000 a year.
By Jackie Stewart Published
-
Roth IRA Contribution Limits for 2024
Roth IRAs Roth IRA contribution limits have gone up for 2024. Here's what you need to know.
By Jackie Stewart Published
-
SIMPLE IRA Contribution Limits for 2024
simple IRA The maximum amount workers at small businesses can contribute to a SIMPLE IRA increased by $500 for 2024.
By Jackie Stewart Published
-
457 Contribution Limits for 2024
retirement plans State and local government workers can contribute more to their 457 plans in 2024 than in 2023.
By Jackie Stewart Published
-
Roth 401(k) Contribution Limits for 2024
retirement plans The Roth 401(k) contribution limit for 2024 is increasing, and workers who are 50 and older can save even more.
By Jackie Stewart Published
-
Four Tips for Renting Out Your Home on Airbnb
real estate Here's what you should know before listing your home on Airbnb.
By Miriam Cross Published
-
Five Ways to a Cheap Last-Minute Vacation
Travel It is possible to pull off a cheap last-minute vacation. Here are some tips to make it happen.
By Vaishali Varu Last updated